Seek Returns logo

MTD vs. TEM: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at MTD and TEM, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolMTDTEM
Company NameMettler-Toledo International Inc.Tempus AI, Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization27.13 billion USD12.73 billion USD
ExchangeNYSENasdaqGS
Listing DateNovember 14, 1997June 14, 2024
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of MTD and TEM by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

MTD vs. TEM: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolMTDTEM
5-Day Price Return0.25%2.36%
13-Week Price Return13.61%14.97%
26-Week Price Return1.52%-12.50%
52-Week Price Return-8.22%27.20%
Month-to-Date Return6.74%29.49%
Year-to-Date Return7.62%117.06%
10-Day Avg. Volume0.15M15.32M
3-Month Avg. Volume0.19M12.07M
3-Month Volatility28.76%79.77%
Beta1.403.14

Profitability

Return on Equity (TTM)

MTD

1,675.84%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

MTD’s Return on Equity of 1,675.84% is exceptionally high, placing it well beyond the typical range for the Life Sciences Tools & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

TEM

-107.12%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

TEM has a negative Return on Equity of -107.12%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

MTD vs. TEM: A comparison of their Return on Equity (TTM) against the Life Sciences Tools & Services industry benchmark.

Net Profit Margin (TTM)

MTD

21.46%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

A Net Profit Margin of 21.46% places MTD in the upper quartile for the Life Sciences Tools & Services industry, signifying strong profitability and more effective cost management than most of its peers.

TEM

-20.98%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

TEM has a negative Net Profit Margin of -20.98%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

MTD vs. TEM: A comparison of their Net Profit Margin (TTM) against the Life Sciences Tools & Services industry benchmark.

Operating Profit Margin (TTM)

MTD

26.49%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

An Operating Profit Margin of 26.49% places MTD in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

TEM

-24.66%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

TEM has a negative Operating Profit Margin of -24.66%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.

MTD vs. TEM: A comparison of their Operating Profit Margin (TTM) against the Life Sciences Tools & Services industry benchmark.

Profitability at a Glance

SymbolMTDTEM
Return on Equity (TTM)1,675.84%-107.12%
Return on Assets (TTM)25.15%-15.77%
Net Profit Margin (TTM)21.46%-20.98%
Operating Profit Margin (TTM)26.49%-24.66%
Gross Profit Margin (TTM)59.94%60.73%

Financial Strength

Current Ratio (MRQ)

MTD

1.12

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

MTD’s Current Ratio of 1.12 falls into the lower quartile for the Life Sciences Tools & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

TEM

1.54

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

TEM’s Current Ratio of 1.54 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

MTD vs. TEM: A comparison of their Current Ratio (MRQ) against the Life Sciences Tools & Services industry benchmark.

Debt-to-Equity Ratio (MRQ)

MTD

81.23

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

With a Debt-to-Equity Ratio of 81.23, MTD operates with exceptionally high leverage compared to the Life Sciences Tools & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

TEM

2.58

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

With a Debt-to-Equity Ratio of 2.58, TEM operates with exceptionally high leverage compared to the Life Sciences Tools & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

MTD vs. TEM: A comparison of their Debt-to-Equity Ratio (MRQ) against the Life Sciences Tools & Services industry benchmark.

Interest Coverage Ratio (TTM)

MTD

15.60

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

MTD’s Interest Coverage Ratio of 15.60 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

TEM

-14.08

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

TEM has a negative Interest Coverage Ratio of -14.08. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.

MTD vs. TEM: A comparison of their Interest Coverage Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Financial Strength at a Glance

SymbolMTDTEM
Current Ratio (MRQ)1.121.54
Quick Ratio (MRQ)0.671.34
Debt-to-Equity Ratio (MRQ)81.232.58
Interest Coverage Ratio (TTM)15.60-14.08

Growth

Revenue Growth

MTD vs. TEM: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

MTD vs. TEM: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

MTD

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

MTD currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

TEM

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

TEM currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

MTD vs. TEM: A comparison of their Dividend Yield (TTM) against the Life Sciences Tools & Services industry benchmark.

Dividend Payout Ratio (TTM)

MTD

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

MTD has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

TEM

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

TEM has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

MTD vs. TEM: A comparison of their Dividend Payout Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Dividend at a Glance

SymbolMTDTEM
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

MTD

32.53

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

MTD’s P/E Ratio of 32.53 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

TEM

--

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

P/E Ratio data for TEM is currently unavailable.

MTD vs. TEM: A comparison of their Price-to-Earnings Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Price-to-Sales Ratio (TTM)

MTD

6.98

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

MTD’s P/S Ratio of 6.98 is in the upper echelon for the Life Sciences Tools & Services industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

TEM

13.37

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

With a P/S Ratio of 13.37, TEM trades at a valuation that eclipses even the highest in the Life Sciences Tools & Services industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

MTD vs. TEM: A comparison of their Price-to-Sales Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Price-to-Book Ratio (MRQ)

MTD

1,299.40

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

At 1,299.40, MTD’s P/B Ratio is at an extreme premium to the Life Sciences Tools & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

TEM

35.53

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

At 35.53, TEM’s P/B Ratio is at an extreme premium to the Life Sciences Tools & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

MTD vs. TEM: A comparison of their Price-to-Book Ratio (MRQ) against the Life Sciences Tools & Services industry benchmark.

Valuation at a Glance

SymbolMTDTEM
Price-to-Earnings Ratio (TTM)32.53--
Price-to-Sales Ratio (TTM)6.9813.37
Price-to-Book Ratio (MRQ)1,299.4035.53
Price-to-Free Cash Flow Ratio (TTM)31.84--